Target intelligence / Profile preview

Protocadherin gamma-C4 (PCDHGC4)

Target
PCDHGC4
Molecular classification
Cell adhesion molecule (cadherin superfamily), Transmembrane protein
01

Overview

Protocadherin gamma-C4 (PCDHGC4) is a calcium-dependent neural cell adhesion molecule belonging to the cadherin superfamily, encoded by the PCDHGC4 gene in the gamma cluster on chromosome 5[1][2][4]. The protocadherin gamma cluster consists of 22 genes subdivided into three subfamilies (A, B, C), and PCDHGC4 is one of three genes in the more distantly related subfamily C[1][2]. Structurally, it is a type I transmembrane protein with six extracellular cadherin (EC) domains and a variable cytoplasmic region, followed by a constant cytoplasmic C-terminal region encoded by shared exons within the cluster[1][4]. PCDHGC4 is essential for establishment and maintenance of specific neuronal connections, and plays a unique, non-redundant role in postnatal neuronal survival, particularly for cortical inhibitory interneurons (cINs) during developmental programmed cell death[2][3]. Genetic disruption of PCDHGC4 in model organisms leads to severe neurodevelopmental phenotypes and early postnatal lethality, illustrating its indispensability[2][3][4]. In humans, loss-of-function mutations are highly constrained and associated with neurodevelopmental disease, suggesting an essential conserved function without redundancy among gamma cluster members[2][3][4][1]. No specific drugs, biomarkers, or safety concerns are associated for therapeutic targeting as of current research[1][2][3][4].

Other names
PCDHGC4Protocadherin gamma subfamily C, 4Protocadherin gamma-C4PCDH-gamma-C4PCDH-GAMMA-C4NEDGS
02

Biological functions

Neural cell-cell adhesionRegulation of neuronal survival (especially cortical interneurons)Formation and maintenance of neural circuitsProgrammed neuronal cell death regulation
03

Disease associations

Neurodevelopmental disorder with poor growth and skeletal anomaliesNon-specific syndromic intellectual disabilityOther (implied roles in neurodevelopmental pathology)

Beyond the preview

Go deeper on Protocadherin gamma-C4 (PCDHGC4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protocadherin gamma-C4 (PCDHGC4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call